Management of Small Testicular Masses: A Delphi Consensus Study

Karl H Pang1, Giuseppe Fallara2, João Lobo3

  • 1Department of Andrology, University College London Hospitals NHS Foundation Trust, London, UK; Division of Surgery and Interventional Science, University College London, London, UK.

European Urology Oncology
|November 5, 2024
PubMed
Abstract

Insights

Radical orchidectomy for small testicular masses may be overtreatment. Consensus recommendations favor personalized management, including surveillance or testis-sparing surgery (TSS), to preserve testicular function.

Area of Science:

  • Urology
  • Oncology
  • Radiology

Background:

  • Small testicular masses (STMs) are frequently benign, making radical orchidectomy (RO) potentially overtreatment.
  • Preserving testicular function through surveillance or testis-sparing surgery (TSS) is crucial for selected patients.
  • Lack of clear guidelines necessitates expert consensus for STM management.

Purpose of the Study:

  • To develop consensus recommendations for the management of small testicular masses (STMs).
  • To provide guidance on selecting appropriate management strategies, balancing cancer risk with testicular function preservation.

Main Methods:

  • A four-round Delphi study involving 24 multidisciplinary experts.
  • Consensus defined as ≥75% agreement within a 3-point grouping.
  • Iterative survey rounds, an online meeting, and final statement review.

Main Results:

  • Developed 96 consensus statements covering assessment and management of STMs.
  • Personalized management based on cancer risk, fertility, tumor characteristics, and ultrasound findings.
  • Solid, hypoechoic, vascular lesions are more suspicious for malignancy.

Conclusions:

  • Expert consensus provides recommendations for STM management.
  • Testis-sparing surgery (TSS) should be considered for STMs.
  • These recommendations aim to disseminate best practices and improve patient outcomes.